NCT02138461View on ClinicalTrials.gov

Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops

CompletedOBSERVATIONAL

Enrollment

211

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Glaucoma

Trial Locations (1)

92653

Harvard Eye Associates, Laguna Hills

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

MDbackline, LLC

OTHER